Non-adherence in non-inferiority trials can affect treatment effect estimates and often increases the chance of claiming non-inferiority under the standard intention-to-treat analysis. This article discusses the implications of different patterns of non-adherence in non-inferiority trials and offers practical recommendations for trial design, alternative analysis strategies, and outcome reporting to reduce bias in treatment estimates and improve transparency in reporting
Background: The interpretation of the results of active-control trials regarding the efficacy and sa...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
With improvements in care over time it becomes harder to improve clinical outcomes in those conditio...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
BACKGROUND: In non-inferiority trials with non-adherence to interventions (or non-compliance), inten...
In drug, device and behavioral clinical trials, patient withdrawal, loss-to-follow-up, and non-compl...
Background The objective of a non-inferiority trial is to determine whether a new or existing treatm...
BACKGROUND: The interpretation of the results of active-control trials regarding the efficacy and sa...
Despite decades of experience with non-inferiority trials, they remain a source of great controversy...
Abstract Background The interpretation of the results of active-control trials regarding the efficac...
ObjectiveTo assess the adequacy of reporting of non-inferiority trials alongside the consistency and...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
Clinical investigators are increasingly testing treatments that have the primary benefit of decrease...
Background: The interpretation of the results of active-control trials regarding the efficacy and sa...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
With improvements in care over time it becomes harder to improve clinical outcomes in those conditio...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
BACKGROUND: In non-inferiority trials with non-adherence to interventions (or non-compliance), inten...
In drug, device and behavioral clinical trials, patient withdrawal, loss-to-follow-up, and non-compl...
Background The objective of a non-inferiority trial is to determine whether a new or existing treatm...
BACKGROUND: The interpretation of the results of active-control trials regarding the efficacy and sa...
Despite decades of experience with non-inferiority trials, they remain a source of great controversy...
Abstract Background The interpretation of the results of active-control trials regarding the efficac...
ObjectiveTo assess the adequacy of reporting of non-inferiority trials alongside the consistency and...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
Clinical investigators are increasingly testing treatments that have the primary benefit of decrease...
Background: The interpretation of the results of active-control trials regarding the efficacy and sa...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
With improvements in care over time it becomes harder to improve clinical outcomes in those conditio...